632 related articles for article (PubMed ID: 7645476)
1. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.
van der Woude HJ; Bloem JL; Verstraete KL; Taminiau AH; Nooy MA; Hogendoorn PC
AJR Am J Roentgenol; 1995 Sep; 165(3):593-8. PubMed ID: 7645476
[TBL] [Abstract][Full Text] [Related]
2. Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy.
Fletcher BD; Hanna SL; Fairclough DL; Gronemeyer SA
Radiology; 1992 Jul; 184(1):243-8. PubMed ID: 1319075
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast enhanced magnetic resonance imaging subtraction in evaluating osteosarcoma response to chemotherapy.
Torricelli P; Montanari N; Spina V; Manfrini M; Bertoni F; Saguatti G; Romagnoli R
Radiol Med; 2001 Mar; 101(3):145-51. PubMed ID: 11402952
[TBL] [Abstract][Full Text] [Related]
4. Treatment of high-grade bone sarcomas with neoadjuvant chemotherapy: the utility of sequential color Doppler sonography in predicting histopathologic response.
van der Woude HJ; Bloem JL; van Oostayen JA; Nooy MA; Taminiau AH; Hermans J; Reynierse M; Hogendoorn PC
AJR Am J Roentgenol; 1995 Jul; 165(1):125-33. PubMed ID: 7785571
[TBL] [Abstract][Full Text] [Related]
5. Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging.
de Baere T; Vanel D; Shapeero LG; Charpentier A; Terrier P; di Paola M
Radiology; 1992 Nov; 185(2):587-92. PubMed ID: 1410378
[TBL] [Abstract][Full Text] [Related]
6. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
[TBL] [Abstract][Full Text] [Related]
7. Preoperative evaluation of osteosarcoma: value of gadopentetate dimeglumine-enhanced MR imaging.
Seeger LL; Widoff BE; Bassett LW; Rosen G; Eckardt JJ
AJR Am J Roentgenol; 1991 Aug; 157(2):347-51. PubMed ID: 1853820
[TBL] [Abstract][Full Text] [Related]
8. Musculoskeletal neoplasm: perineoplastic edema versus tumor on dynamic postcontrast MR images with spatial mapping of instantaneous enhancement rates.
Lang P; Honda G; Roberts T; Vahlensieck M; Johnston JO; Rosenau W; Mathur A; Peterfy C; Gooding CA; Genant HK
Radiology; 1995 Dec; 197(3):831-9. PubMed ID: 7480764
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging.
Murakami T; Nakamura H; Tsuda K; Nakanishi K; Hori S; Tomoda K; Mitani T; Kozuka T; Monden M; Wakasa K
AJR Am J Roentgenol; 1993 Feb; 160(2):295-9. PubMed ID: 8380948
[TBL] [Abstract][Full Text] [Related]
10. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol].
Liu R; Wang JH; Zhou KR; Yan FH; Yan ZP; Shen JZ; Tan YS; Cai Y
Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):754-8. PubMed ID: 16248948
[TBL] [Abstract][Full Text] [Related]
11. Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing's sarcoma: review of current imaging modalities.
van der Woude HJ; Bloem JL; Hogendoorn PC
Skeletal Radiol; 1998 Feb; 27(2):57-71. PubMed ID: 9526770
[TBL] [Abstract][Full Text] [Related]
12. The potential of MRI in preoperative evaluation of chemotherapy-induced necrosis in osteosarcoma and Ewing's sarcoma.
Maas R; Winkler K; Delling G; Heise U
Chir Organi Mov; 1990; 75(1 Suppl):41-4. PubMed ID: 2249554
[No Abstract] [Full Text] [Related]
13. The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas.
Holscher HC; Bloem JL; Nooy MA; Taminiau AH; Eulderink F; Hermans J
AJR Am J Roentgenol; 1990 Apr; 154(4):763-9. PubMed ID: 2107673
[TBL] [Abstract][Full Text] [Related]
14. Monitoring neovascularity as an indicator to response to chemotherapy in osteogenic and Ewing sarcoma using magnetic resonance angiography.
Lang P; Vahlensieck M; Matthay KK; Johnston JO; Rosenau W; Gooding CA; Genant HK
Med Pediatr Oncol; 1996 May; 26(5):329-33. PubMed ID: 8614366
[TBL] [Abstract][Full Text] [Related]
15. Detection of areas with viable remnant tumor in postchemotherapy patients with Ewing's sarcoma by dynamic contrast-enhanced MRI using pharmacokinetic modeling.
Egmont-Petersen M; Hogendoorn PC; van der Geest RJ; Vrooman HA; van der Woude H; Janssen JP; Bloem JL; Reiber JH
Magn Reson Imaging; 2000 Jun; 18(5):525-35. PubMed ID: 10913714
[TBL] [Abstract][Full Text] [Related]
16. Arterial-phase three-dimensional contrast-enhanced MR angiography of the carotid arteries.
Levy RA; Prince MR
AJR Am J Roentgenol; 1996 Jul; 167(1):211-5. PubMed ID: 8659374
[TBL] [Abstract][Full Text] [Related]
17. [Place of the pathologist in the management of primary bone tumors (osteosarcoma and Ewing's family tumors after neoadjuvant treatment)].
Gomez-Brouchet A; Bouvier C; Decouvelaere AV; Larousserie F; Aubert S; Leroy X; Guinebretière JM; Coulomb A; Cassagnau E; de Muret A; Audard V; Marie B; de Pinieux G
Ann Pathol; 2011 Dec; 31(6):455-65. PubMed ID: 22172118
[TBL] [Abstract][Full Text] [Related]
18. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
Low RN; Sigeti JS
AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
Bartolozzi C; Lencioni R; Caramella D; Mazzeo S; Ciancia EM
AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000
[TBL] [Abstract][Full Text] [Related]
20. Cartilaginous tumors: correlation of gadolinium-enhanced MR imaging and histopathologic findings.
Geirnaerdt MJ; Bloem JL; Eulderink F; Hogendoorn PC; Taminiau AH
Radiology; 1993 Mar; 186(3):813-7. PubMed ID: 8430192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
